Nazione: Australia
Lingua: inglese
Fonte: Department of Health (Therapeutic Goods Administration)
clopidogrel besilate, Quantity: 111.86 mg (Equivalent: clopidogrel, Qty 75 mg)
Southern Cross Pharma Pty Ltd
clopidogrel besilate
Tablet, film coated
Excipient Ingredients: mannitol; microcrystalline cellulose; colloidal anhydrous silica; stearic acid; hypromellose; titanium dioxide; iron oxide red
Oral
28 tablet
(S4) Prescription Only Medicine
Prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.,Acute Coronary Syndrome,Clopidogrel is indicated in combination with aspirin for patients with,-Unstable angina or non-ST-elevation myocardial infarction in order to prevent early and long-termatherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). Clopidogrel is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or PCI, with or without stent).,- ST-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. In thispopulation, clopidogrel has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.
Visual Identification: Pink, round, biconvex tablets with smooth surfaces; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2010-09-09
CLOPIDOGREL APOTEX TABLETS CLOPIDOGREL APOTEX TABLETS _Contains the active ingredient clopidogrel (as besilate) _ CONSUMER MEDICINE INFORMATION _FOR A COPY OF A LARGE PRINT LEAFLET, PH: 1800 195 055 _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about this medicine. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT THIS MEDICINE IS USED FOR Clopidogrel APOTEX contains the active ingredient clopidogrel (as besilate). Clopidogrel belongs to a group of medicines known as antiplatelet medicines. Antiplatelet medicines prevent the clumping of very small blood cells (platelets) to reduce the chances of blood clots forming. Clopidogrel is used to prevent blood clots forming in hardened blood vessels as they can lead to events such as stroke, heart attack or death. You may have been prescribed clopidogrel because you have: • previously suffered a heart attack, stroke, or have a condition known as peripheral arterial disease (leg pain on walking or at rest) • suffered acute coronary syndrome (either a severe type of chest pain called unstable angina, or a heart attack) – in this case you may also be prescribed aspirin ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed this medicine for another reason. There is no evidence that this medicine is addictive. This medicine is available only with a doctor's prescription. This medicine should not be used in children. BEFORE YOU TAKE THIS MEDICINE _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE THIS MEDICINE IF YOU HAVE AN ALLERGY TO: • any medicine containing clopidogrel • other antiplatelet medicines (su Leggi il documento completo
AUSTRALIAN PRODUCT INFORMATION CLOPIDOGREL APOTEX (CLOPIDOGREL) 75 MG TABLET _ _ 1. NAME OF THE MEDICINE Clopidogrel 2. QUALITATIVE AND QUANTITATIVE COMPOSITION CLOPIDOGREL APOTEX film coated tablets contain the active ingredient Clopidogrel (as besilate). Each CLOPIDOGREL APOTEX film coated tablet contains 75 mg of Clopidogrel (as besilate). For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS. 3. PHARMACEUTICAL FORM CLOPIDOGREL APOTEX 75 mg tablets are pink coloured, round biconvex film coated with a smooth surface. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease. ACUTE CORONARY SYNDROME Clopidogrel is indicated in combination with aspirin for patients with: • Unstable angina or non-ST-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). Clopidogrel is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or PCI, with or without stent). • ST-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. In this population, clopidogrel has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy. 4.2. DOSE AND METHOD OF ADMINISTRATION Clopidogrel should be taken once a day with or without food. ADULTS Generally, clopidogrel should be given as a single daily dose of 75 mg. In patients with acute coronary syndrome: • unstable angina or non-ST-elevation myocardial infarction - clopidogrel treatment should be initiated with a single 300 mg loading dose and then continued long-term at 75 mg once a day (with aspirin 75 mg- 325 mg daily). • ST segment elevation acute Leggi il documento completo